Table 3.
Proposal to replace high WC by high ABSI as the criterion of abdominal obesity in the diagnosis of MetS
| Japanese criteria | IDF criteria for Asians | NCEP-ATPIII criteria | |
|---|---|---|---|
| Definition of MetS | (1) + any 2 or more of (2) to (4) | (1) + any 2 or more of (2) to (5) | 3 or more of (1) to (5) |
| Components | |||
| Abdominal obesity | (1) WC ≥85 cm (males), ≥90 cm (females) | (1) WC ≥90 cm (males), ≥80 cm (females) | (1) WC ≥102 cm (males), ≥88 cm |
| (females) | |||
| Proposal to replace high WC by high ABSI (≥ 0.080, both sexes) as the criteria of abdominal obesity | |||
| Hypertension | (2) SBP ≥130 mm Hg and/or DBP | (2) SBP ≥130 mm Hg and/or DBP | (2) SBP ≥130 mm Hg and/or DBP |
| ≥85 mm Hg | ≥85 mm Hg | ≥85 mm Hg | |
| Hyperglycemia | (3) FPG ≥110 mg/dL | (3) FPG ≥100 mmol/L | (3) FPG ≥100 mg/dL |
| Dyslipidemia | (4) TG ≥150 mg/dL and/or HDL-C | (4) TG ≥150 mg/dL | (4) TG ≥150 mg/dL |
| <40 mg/dL | |||
| (5) HDL-C <40 mg/dL (males), <50 mg/dL (females) | (5) HDL-C <40 mg/dL (males), <50 mg/dL (females) | ||
WC, weight circumference; ABSI, a body shape index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; TG, triglyceride; MetS, metabolic syndrome; IDF, International Diabetes Federation; NCEP-ATPIII, National Cholesterol Education Program-Adult Treatment Panel III.